InChI=1S/C19H28O3/c1- 12- 3- 7- 18- 14(9- 12) 5- 4- 13(2) 17(18) 8- 6- 16- 10- 15(20) 11- 19(21) 22- 16/h4- 5,9,12- 13,15- 18,20H,3,6- 8,10- 11H2,1- 2H3/t12- ,13+,15- ,16- ,17+,18+/m1/s1 |
BKZPCUPKVCPRQW-MHMDBQTNSA-N |
C[C@@H]1CC[C@@H]2[C@@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H](C)C=CC2=C1 |
|
Aspergillus terreus
(NCBI:txid33178)
|
of strain
ATCC 20542
See:
PubMed
|
Monascus ruber
(NCBI:txid89489)
|
of strain
M 4681
See:
PubMed
|
Aspergillus metabolite
Any fungal metabolite produced during a metabolic reaction in the mould, Aspergillus .
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor
Any EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that inhibits HMG-CoA reductases. Hydroxymethylglutaryl-CoA reductase inhibitors have been shown to lower directly cholesterol synthesis. The Enzyme Commission designation is EC 1.1.1.34 for the NADPH-dependent enzyme and EC 1.1.1.88 for an NADH-dependent enzyme.
|
|
anticholesteremic drug
A substance used to lower plasma cholesterol levels.
|
|
View more via ChEBI Ontology
(4R,6R)- 6- {2- [(1S,2S,6R,8aR)- 2,6- dimethyl- 1,2,6,7,8,8a- hexahydronaphthalen- 1- yl]ethyl}- 4- hydroxyoxan- 2- one
|
(4R,6R)- 6- {2- [(1S,2S,6R,8aR)- 2,6- dimethyl- 1,2,6,7,8,8a- hexahydronaphthalen- 1- yl]ethyl}- 4- hydroxytetrahydro- 2H- pyran- 2- one
|
IUPAC
|
monacolin L lactone
|
ChEBI
|
79394-47-1
|
CAS Registry Number
|
ChemIDplus
|
8791298
|
Reaxys Registry Number
|
Reaxys
|
21495633
|
PubMed citation
|
SUBMITTER
|
22995742
|
PubMed citation
|
Europe PMC
|
24534845
|
PubMed citation
|
Europe PMC
|
2708134
|
PubMed citation
|
Europe PMC
|
2921224
|
PubMed citation
|
SUBMITTER
|
|